| Tag | Content |
|---|
EnhancerAtlas ID | HS060-20725 |
Organism | Homo sapiens |
Tissue/cell | GM12891 |
Coordinate | chr2:216872350-216874380 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| TCF7L2 | MA0523.1 | chr2:216874132-216874146 | AAAGTTCAAAGCAA | + | 6.03 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_32692 | chr2:216865522-216875187 | GM12878 | | SE_59338 | chr2:216865814-216923900 | Ly3 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH02I216007 | chr2 | 216872524 | 216872923 | | GH02I216008 | chr2 | 216873124 | 216875123 |
|
Enhancer Sequence | CCACGTTGGC CAGGCTGGTC TCATACTGCT GACCTCAAGT GATCCACCTG TCTTGGTCTT 60
CCGAAGTGCT GGGATTACAG GTGTGAGCCA CTGCACCCAA CCCCCACTTA GCGGCTTTTT 120
TTTTGCATTT TTGTACTTTT AGCTGGCAAT TTCACTGTTT AGAATATCTC CCAAAGTGTA 180
GTGCTGAAGT GCTAACATAC ATGTTGGATA AGCTTCACTC CAACCTGAGA TATAGGGTGT 240
TGGCCATGAG TTCAATGTTG ATAGAGCAAC AATATATATT AAATAAGGTG TCTTTAGGCA 300
GAAACACATA AAAAAAGTTA TGCATTGATT GGTTGACAGG GATCTAATCC TGCCATCGGC 360
TCACAGGAAC CTAACTCTGT ATTTCCCCTA GGAACAATGG TTCAGTATTC ACTAATTCAG 420
TGTTCAAGCG ACTTTACAGA ACCTAACTAC CACAGACAAC AAGAATCAGC TGTGCTTCAT 480
AGGGCTATGG TGGGGATTTC ATTAACAGAT ATAGAAGAAA TGGTTTAGTT TGAGTCACGC 540
CGCTTGGGGC AGAGACTGAG TTGAAGAGGA AAGTGTCTCT GACAAGGAAG TTCATCTTCC 600
CTGCCCTCAT GCTCCTGATC CTGTACAGAT TGGGCTTAGT GCTTGTGACA GACTAGGCAC 660
TGTTGTAAAT GCTTTGTATC TGTGGGCCAT TCAGGAAAAT TCAATTTGTA ACAATTGTTA 720
CTCTCTAATT TCTATTAGCT GTTAATAACT GATAATCAAA CATCGTTACA TCTGTCTGAT 780
TTTTCAACAG CAAAAGAAGA AATGGAAAGA ATGAACAACA ATAGCTATGA TTTTATGTGT 840
GGCTCTCTCT TAAGCCACCC AAGTGGACCA TATAATGAGC TTCCAAATCT GTTTTGCTCC 900
TTGTTCATCT GGATGCCCAC CTGCAGCTTC CATTCATGAT AACAAACTTG ATGCCCTCTG 960
CAGGCAATGA ATGGACAGAC GTCACTGTTT TATTTTTCTA CAGTGCCTGA ATTCCTGGGA 1020
GGGAAAGTAA AATAAAATCT CAGTTTGCTC TAGATGACTG TTTTGTGCCC ACACAAAGGA 1080
CCATTCTAAA AAGGAATTGA TCAGGACCTT CGGGTGTGGG CCAAATTCAA AACAAATTGA 1140
ATTTTCCTGA ATGGCCCACA GATACAAAGC ATTTACAACA GTGCCTAGTC TGTCACAAGC 1200
ACTAAGCCCA ATCTGTACAG GATCAGGAGC ATGAGGGCAG GGAAGATGAA CTTCCTTGTC 1260
AGAGACACTT TCCTCTTCAA CTCAGTCTCT GCCCCAAGCG GCGTGACTCA AACTAAACCA 1320
TTTCTGCTAT ATCTGTTAAT GAAATCCCCA CCATAGCCCT ATGAAGCACA GCTGATTCTT 1380
GTTGTCTGTG GTAGTTAGGT TCTGTAAAGT CGCTTGAACA CTGAATTAGT GAATACTGAA 1440
CCATTGTTCC TAGGGGAAAT ACAGAGTTAG GTTCCTGTGA GCCGATGGCA GGATTAGATC 1500
CCTGTCAACC AATCAATACA TAACTTTGTT TTATGTGTTT CTGCCTAAAG ACACCTTATT 1560
TAATATATAT TGTTGCTCTA TCAACATTGA ACTCATGGCC AACACCCTAT ATCTCAGGTT 1620
GGAGTGAAGC TTATCCAACA TGTATGTTAG CACTTCAGCA CTACACTTTG GGAGATATTC 1680
TAAACAGTGA AATTGCCAGC TAAAGTACAA AAATGCAAAA AAAAAAATGC TGCTAAGTGG 1740
GGGTTGGGTG CAGTGGCTCA CACCTGTAAT CCCAGCACTG AAAAAGTTCA AAGCAACCCT 1800
TGTGAAAGAT CCTTCGGTGC ATGACATTTA CACCACAGCC AGCTTCTCTG TGTTCTGATT 1860
CAGCATCTCC CAGGCCTCTG ATGTCTGTAT TAGATCCTAC ATGGCAGTAG GCTCCATGGT 1920
GCCAAAAGAC CTGAGCGTCT TTCTCCTTAA AGGTGACTGC AGCTGTGCCT CCAGGAACAC 1980
AAACATGCTC AGGAGAATCA CATGTTCAAG CGATTCTCCT GCCTCAGCCT 2030
|
